Projects per year
Personal profile
Education
- 國立成功大學臨床醫學研究所博士
Experience
- 2001年01月 ~迄今 胃腸肝膽科醫師
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where I-Chin Wu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
利用次世代定序分析與HepG2-NTCP感染模式探討B型肝炎病毒前基因體核糖核酸剪接與準種對於慢性B型肝炎病人接受抗病毒治療臨床預後的影響
19-08-01 → 20-07-31
Project: Research project
-
利用次世代定序分析與HepG2-NTCP感染模式探討B型肝炎病毒前基因體核糖核酸剪接與準種對於慢性B型肝炎病人接受抗病毒治療臨床預後的影響
19-08-01 → 20-07-31
Project: Research project
-
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
Chiang, H. C., Lee, Y. C., Chang, T. T., Lin, Y. J., Wu, H. T., Wang, C. T., Chen, C. Y., Chen, P. J., Hsieh, M. T., Lin, S. H., Chen, S. H., Chuang, C. H., Wu, I. C., Hong, T. C., Wu, J. S., Han, M. Z., Chen, W. T., Chiang, C. M., Hung, K. K. & Kuo, H. Y., 2023 Feb, In: Cancers. 15, 3, 854.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
Kuo, H. Y., Han, M. Z., Liao, C. H., Lin, Y. J., Wang, C. T., Chen, S. H., Chang, T. T., Chen, P. J., Lin, S. H., Chen, C. Y., Chuang, C. H., Wu, I. C., Wu, J. S., Hong, T. C., Hsieh, M. T., Lee, Y. C., Wu, H. T. & Tsai, H. M., 2022 Nov, In: Pharmaceutics. 14, 11, 2263.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Clinical implications of serum hepatitis b virus pregenomic rna kinetics in chronic hepatitis b patients receiving antiviral treatment and those achieving hbsag loss
Wu, I. C., Liu, W. C., Chiu, Y. C., Chiu, H. C., Cheng, P. N. & Chang, T. T., 2021 Jun, In: Microorganisms. 9, 6, 1146.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan
Chiu, H. C., Chiu, Y. C., Yang, E. H., Chang, T. T., Chien, S. C., Wu, I. C., Wu, C. H. & Cheng, P. N., 2021 Mar, In: Journal of the Formosan Medical Association. 120, 3, p. 983-990 8 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
Tsai, H. M., Han, M. Z., Lin, Y. J., Chang, T. T., Chen, C. Y., Cheng, P. N., Chuang, C. H., Wu, I. C., Chen, P. J., Kang, J. W., Chiu, Y. C., Chiu, H. C., Chien, S. C. & Kuo, H. Y., 2021 Jul, In: Cancer Immunology, Immunotherapy. 70, 7, p. 1929-1937 9 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Citations (Scopus)